Table 1 Selected patient and tumor characteristics
From: Volumetric and MGMT parameters in glioblastoma patients: Survival analysis
N = 65 | Â | Â |
|---|---|---|
Age (years) | Â | Median (range) |
   Median |  | 59 (22-74) |
| Â | Â | N (%) |
   < 50 |  | 15 (23) |
   ≥ 50 |  | 50 (77) |
Sex | Â | Â |
   Male |  | 37 (57) |
   Female |  | 28 (43) |
PS | Â | Â |
   0 |  | 34 (52) |
   1 |  | 25 (38) |
   2 |  | 6 (9) |
Surgery | Â | Â |
   Partial/Biopsy* |  | 19 (29) |
   Sutotal resection |  | 33 (51) |
   Total resection |  | 13 (20) |
Hemisphere | Â | Â |
   Left |  | 33 (51) |
   Right |  | 29 (45) |
   Bilateral |  | 3 (5) |
Location | Â | Â |
   Temporal |  | 20 (31) |
   Parietal |  | 20 (31) |
   Occipital |  | 3 (5) |
   Frontal |  | 17 (26) |
   Deep |  | 8 (12) |
Volumetric parameters | Â | Median (range) |
| Â | Enhancing tumor (cm3) | 34.7 (2.3-117.5) |
   Preoperative | T2 abnormality (cm3) | 108.1 (3.8-230.9) |
| Â | Necrosis (cm3) | 5.8 (0-57) |
   PreRCT | Net-enhancing tumor (cm3) | 11 (0-80.8) |